{"public_id":"cl_90d1fa0e7e6629275ebe6f2f2027e15f","status":"active","superseded_by_public_id":null,"corpus_id":251478343,"text":"Clinical trials and real-world studies on brolucizumab are reviewed for efficacy and safety in degenerative macular disorders.","confidence":0.96,"paper":{"corpus_id":251478343,"title":"Brolucizumab for the Treatment of Degenerative Macular Conditions: A Review of Clinical Studies","url":"https://sah.borca.ai/papers/251478343"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.96,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_0b8dd3a1cfe0a49ba3fa4d93a998cb11","name":"clinical trials","description":"Controlled clinical studies evaluating the efficacy and safety of an intervention.","types":["study type"],"url":"https://sah.borca.ai/concepts/co_0b8dd3a1cfe0a49ba3fa4d93a998cb11"},{"public_id":"co_865570baee5ef6608650da554fe5c363","name":"real-world studies","description":"Observational studies reporting outcomes from routine clinical practice.","types":["study type"],"url":"https://sah.borca.ai/concepts/co_865570baee5ef6608650da554fe5c363"},{"public_id":"co_97afb39964f8ce4b4733dc01c6a6c039","name":"degenerative macular disorders","description":"A group of retinal macular diseases associated with degeneration and vision impairment.","types":["disease category"],"url":"https://sah.borca.ai/concepts/co_97afb39964f8ce4b4733dc01c6a6c039"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_90d1fa0e7e6629275ebe6f2f2027e15f"}